Covalon Reports on 2026 First Quarter Results and Recent Achievements and Highlights Life Science Investing
Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on PET Scans in na-SPMS Patients with PIRA Life Science Investing
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in March Life Science Investing
BioRestorative Expands Global Protection for ThermoStem®, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs Life Science Investing
Candel Therapeutics to Present at TD Cowen's 46th Annual Health Care Conference in Boston Life Science Investing
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer
